Apoptosis in the kidneys of patients with type II diabetic nephropathy

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 72, Issue 7, Pages (October 2007)
Volume 65, Issue 1, Pages (January 2004)
Increased expression of heparanase in overt diabetic nephropathy
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 82, Issue 7, Pages (October 2012)
Volume 69, Issue 3, Pages (February 2006)
Volume 81, Issue 11, Pages (June 2012)
Volume 58, Issue 1, Pages (July 2000)
Testosterone promotes apoptotic damage in human renal tubular cells
Volume 62, Issue 1, Pages (July 2002)
Volume 58, Issue 1, Pages (July 2000)
Volume 72, Issue 6, Pages (September 2007)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 74, Issue 1, Pages (July 2008)
Volume 82, Issue 7, Pages (October 2012)
Volume 69, Issue 12, Pages (June 2006)
Volume 68, Issue 2, Pages (August 2005)
Volume 65, Issue 1, Pages (January 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 58, Issue 6, Pages (December 2000)
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
JAK/STAT signaling in renal diseases
Volume 86, Issue 6, Pages (December 2014)
Volume 69, Issue 1, Pages (January 2006)
Volume 70, Issue 3, Pages (August 2006)
Volume 79, Issue 7, Pages (April 2011)
Volume 87, Issue 2, Pages (February 2015)
Marie Claire Gubler, Corinne Antignac  Kidney International 
Volume 77, Issue 9, Pages (May 2010)
Volume 75, Issue 12, Pages (June 2009)
AOPPs and the progression of kidney disease
Volume 60, Issue 1, Pages (July 2001)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Myeloma cast nephropathy, direct renal infiltration by myeloma, and renal extramedullary hematopoiesis  S.H. Nasr, B.B. Alobeid, J.A. Otrakji, G.S. Markowitz 
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 70, Issue 11, Pages (December 2006)
Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis  J. Mahmood, F. Khan, S. Okada,
Blood pressure targets in hemodialysis patients
Volume 69, Issue 12, Pages (June 2006)
An unusual cause of acute renal failure
Hypertension, race, and glomeruli: more than simply a numbers game
Volume 72, Issue 2, Pages (July 2007)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 70, Issue 6, Pages (September 2006)
Volume 82, Issue 3, Pages (August 2012)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 72, Issue 7, Pages (October 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 59, Issue 5, Pages (May 2001)
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Volume 69, Issue 11, Pages (June 2006)
Volume 69, Issue 11, Pages (June 2006)
Volume 71, Issue 7, Pages (April 2007)
Acute phosphate nephropathy
Volume 69, Issue 7, Pages (April 2006)
Volume 73, Issue 3, Pages (February 2008)
Volume 57, Issue 5, Pages (May 2000)
Volume 70, Issue 2, Pages (July 2006)
Volume 69, Issue 10, Pages (May 2006)
A nest in renal fibrosis?
Amylin deposition in the kidney of patients with diabetic nephropathy
Volume 73, Issue 5, Pages (March 2008)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Volume 70, Issue 1, Pages (July 2006)
Acute phosphate nephropathy
Presentation transcript:

Apoptosis in the kidneys of patients with type II diabetic nephropathy D. Verzola, M.T. Gandolfo, F. Ferrario, M.P. Rastaldi, B. Villaggio, F. Gianiorio, M. Giannoni, L. Rimoldi, F. Lauria, M. Miji, G. Deferrari, G. Garibotto  Kidney International  Volume 72, Issue 10, Pages 1262-1272 (November 2007) DOI: 10.1038/sj.ki.5002531 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Glomerular and tubular apoptosis by ssDNA antibodies analysis. Serial sections of kidneys with type II diabetic nephropathy were stained for apoptosis using the ssDNA Ab. Black arrows point to cells that display the nuclear fragmentation and condensation characteristic of apoptosis. The anti-ssDNA signal was not only confined to glomerular cells (a and b, mesangial cells; c, podocytes; d, endothelial cells), but it was also detected (e, f) in tubular and (g, h) vascular endothelial cells (original magnification × 1000). Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Apoptosis in the kidneys of patients with type II diabetic nephropathy. (a) Patients with type II diabetic nephropathy (DN) presented an increase in apoptotic index both in the glomeruli and tubuli when compared to controls and patients affected by nondiabetic nephropathies (GN). (b) Apoptosis was similarly enhanced both in patients with early and in those with advanced clinical impairment. aP<0.05; bP<0.01 vs controls and patients with GN and proteinuria. Mean±s.e.m. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Cell fate in type II diabetic nephropathy. Apoptosis and proliferation were quantified in the glomeruli and tubules in kidney biopsies from patients with type II DN. In these patients, the proliferation/apoptosis ratio was markedly decreased in favor of apoptosis both in glomeruli and tubuli. aP<0.05; bP<0.01 vs controls. Mean±s.e.m. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Apoptosis in the kidneys of patients with type II diabetic nephropathy. Apoptosis was directly associated with HbA1c levels in the (a) glomeruli but not in (b) tubule cells in patients with type II diabetic nephropathy. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Apoptosis in the kidneys of patients with type II diabetic nephropathy. Apoptosis was directly associated with systolic blood pressure in the (a) glomeruli but not in (b) tubule cells in patients with type II diabetic nephropathy. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 6 Apoptosis in the kidneys of patients with type II diabetic nephropathy. Apoptosis was associated with plasma LDL-cholesterol in (b) tubule but not in (a) glomerular cells in patients with type II diabetic nephropathy. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 7 Expression of Fas (immunohistochemistry) in (a–c) controls and in (d–f) kidney biopsies from patients with type II diabetic nephropathy (c–f: original magnification × 400; a, b: original magnification × 1000). Results of image analysis are shown in g and h (aP<0.05 vs controls). Fas expression was clearly upregulated both in glomeruli and tubuli. Mean±s.e.m. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 8 Expression of FasL (immunohistochemistry and immunofluorescence) in (a, d) controls and in (b, c, e, f, h, i) patients with type II diabetic nephropathy. FasL was upregulated both in the glomeruli and tubuli in patients with diabetic nephropathy. (j, k) Image analysis (aP<0.05, bP<0.01 vs controls) (b, g, h: original magnification × 400; a, d, f, i: original magnification × 1000). Mean±s.e.m. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 9 Relationships between Fas/FasL expression in the kidney and estimated GFR. FasL expression was inversely related to estimated GFR in (b) the glomeruli, but not in (d) tubuli, in patients with type II diabetic nephropathy. (a) Glomerular and (c) tubular Fas expression was not related to estimated GFR. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 10 Expression of phosphorylated p38 MAPK (immunohistochemistry) in (a) controls (original magnification × 400) and in (b–d) patients with type II diabetic nephropathy (original magnification × 1000). Phosphorylated p38 was upregulated in glomerular, tubular (aP<0.05 vs controls), and vascular endothelial cells (a: original magnification × 400; b–d: original magnification × 1000). Data±s.e.m. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 11 Relationships between (a) glomerular and (b) tubule cell apoptosis and loss of renal function at 2 years in patients with type II diabetic nephropathy and proteinuria. Kidney International 2007 72, 1262-1272DOI: (10.1038/sj.ki.5002531) Copyright © 2007 International Society of Nephrology Terms and Conditions